Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • First Disclosures
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • First Disclosures
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Article

  • Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers
    Masaaki Komatsu, Keiko Hiyama, Keiji Tanimoto, Mayu Yunokawa, Keiko Otani, Megu Ohtaki, Eiso Hiyama, Junzo Kigawa, Michitaka Ohwada, Mitsuaki Suzuki, Nobutaka Nagai, Yoshiki Kudo, Masahiko Nishiyama
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 767-775; DOI: 10.1158/1535-7163.MCT-05-0408
  • Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non–small cell lung cancer cells (H1299)
    Elvira Crescenzi, Angela Chiaviello, Gianfranco Canti, Elena Reddi, Bianca Maria Veneziani, Giuseppe Palumbo
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 776-785; DOI: 10.1158/1535-7163.MCT-05-0425
  • Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells
    Ruoping Tang, Anne-Marie Faussat, Patricia Majdak, Christophe Marzac, Sabine Dubrulle, Zora Marjanovic, Ollivier Legrand, Jean-Pierre Marie
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 723-731; DOI: 10.1158/1535-7163.MCT-05-0164
  • Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine
    Tomio Ueno, Sae Hee Ko, Elizabeth Grubbs, Yasunori Yoshimoto, Christi Augustine, Zeinab Abdel-Wahab, Tsung-Yen Cheng, Omar I. Abdel-Wahab, Scott K. Pruitt, Henry S. Friedman, Douglas S. Tyler
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 732-738; DOI: 10.1158/1535-7163.MCT-05-0098
  • Identification of a small topoisomerase I–binding peptide that has synergistic antitumor activity with 9-aminocamptothecin
    Christopher D. Pond, Kathryn M. Marshall, Louis R. Barrows
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 739-745; DOI: 10.1158/1535-7163.MCT-05-0377
  • Sulindac independently modulates extracellular signal–regulated kinase 1/2 and cyclic GMP–dependent protein kinase signaling pathways
    Pamela L. Rice, Stevany L. Peters, K. Scott Beard, Dennis J. Ahnen
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 746-754; DOI: 10.1158/1535-7163.MCT-05-0210
  • Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
    Svetlana Komarova, Yosuke Kawakami, Mariam A. Stoff-Khalili, David T. Curiel, Larisa Pereboeva
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 755-766; DOI: 10.1158/1535-7163.MCT-05-0334
  • Survivin and Granzyme B–induced apoptosis, a novel anticancer therapy
    Hugo Caldas, Florinda O. Jaynes, Michael W. Boyer, Sue Hammond, Rachel A. Altura
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 693-703; DOI: 10.1158/1535-7163.MCT-05-0423
  • NIK-333 inhibits growth of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells in association with blockade of nuclear factor-κB signal pathway
    Taeko Okudaira, Mariko Tomita, Jun-Nosuke Uchihara, Takehiro Matsuda, Chie Ishikawa, Hirochika Kawakami, Masato Masuda, Yuetsu Tanaka, Kazuiku Ohshiro, Nobuyuki Takasu, Naoki Mori
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 704-712; DOI: 10.1158/1535-7163.MCT-05-0434
  • Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells
    Mariya Farooqui, Zhen H. Geng, Elliot J. Stephenson, Nurulain Zaveri, Douglas Yee, Kalpna Gupta
    Molecular Cancer Therapeutics Mar 2006, 5 (3) 611-620; DOI: 10.1158/1535-7163.MCT-05-0016

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 69
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement